Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
Possible immunogenicity of the Cas9 protein raises concerns about therapeutic applications. Here the authors identify pre-existing CD8+T-cell immunity in healthy individuals and in response modify Cas9 to remove the immunodominant epitopes.
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7163fcf8bec84bbaa28f45dd3cb383d7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7163fcf8bec84bbaa28f45dd3cb383d7 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7163fcf8bec84bbaa28f45dd3cb383d72021-12-02T15:36:18ZMultifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes10.1038/s41467-019-09693-x2041-1723https://doaj.org/article/7163fcf8bec84bbaa28f45dd3cb383d72019-04-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-09693-xhttps://doaj.org/toc/2041-1723Possible immunogenicity of the Cas9 protein raises concerns about therapeutic applications. Here the authors identify pre-existing CD8+T-cell immunity in healthy individuals and in response modify Cas9 to remove the immunodominant epitopes.Shayesteh R. FerdosiRadwa EwaishaFarzaneh MoghadamSri KrishnaJin G. ParkMo R. EbrahimkhaniSamira KianiKaren S. AndersonNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-10 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Shayesteh R. Ferdosi Radwa Ewaisha Farzaneh Moghadam Sri Krishna Jin G. Park Mo R. Ebrahimkhani Samira Kiani Karen S. Anderson Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes |
description |
Possible immunogenicity of the Cas9 protein raises concerns about therapeutic applications. Here the authors identify pre-existing CD8+T-cell immunity in healthy individuals and in response modify Cas9 to remove the immunodominant epitopes. |
format |
article |
author |
Shayesteh R. Ferdosi Radwa Ewaisha Farzaneh Moghadam Sri Krishna Jin G. Park Mo R. Ebrahimkhani Samira Kiani Karen S. Anderson |
author_facet |
Shayesteh R. Ferdosi Radwa Ewaisha Farzaneh Moghadam Sri Krishna Jin G. Park Mo R. Ebrahimkhani Samira Kiani Karen S. Anderson |
author_sort |
Shayesteh R. Ferdosi |
title |
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes |
title_short |
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes |
title_full |
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes |
title_fullStr |
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes |
title_full_unstemmed |
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes |
title_sort |
multifunctional crispr-cas9 with engineered immunosilenced human t cell epitopes |
publisher |
Nature Portfolio |
publishDate |
2019 |
url |
https://doaj.org/article/7163fcf8bec84bbaa28f45dd3cb383d7 |
work_keys_str_mv |
AT shayestehrferdosi multifunctionalcrisprcas9withengineeredimmunosilencedhumantcellepitopes AT radwaewaisha multifunctionalcrisprcas9withengineeredimmunosilencedhumantcellepitopes AT farzanehmoghadam multifunctionalcrisprcas9withengineeredimmunosilencedhumantcellepitopes AT srikrishna multifunctionalcrisprcas9withengineeredimmunosilencedhumantcellepitopes AT jingpark multifunctionalcrisprcas9withengineeredimmunosilencedhumantcellepitopes AT morebrahimkhani multifunctionalcrisprcas9withengineeredimmunosilencedhumantcellepitopes AT samirakiani multifunctionalcrisprcas9withengineeredimmunosilencedhumantcellepitopes AT karensanderson multifunctionalcrisprcas9withengineeredimmunosilencedhumantcellepitopes |
_version_ |
1718386359124623360 |